Experiment: 5M0A

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCA	10 mM TRIS, 150 mM sodium chloride, 0.02 ug/mL TSP, 1 mM sodium azide, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 0.5 mM EDTA	90% H2O/10% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 800
2	3D HN(CO)CA	10 mM TRIS, 150 mM sodium chloride, 0.02 ug/mL TSP, 1 mM sodium azide, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 0.5 mM EDTA	90% H2O/10% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 800
3	3D HNCACB	10 mM TRIS, 150 mM sodium chloride, 0.02 ug/mL TSP, 1 mM sodium azide, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 0.5 mM EDTA	90% H2O/10% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 800
4	3D HN(COCA)CB	10 mM TRIS, 150 mM sodium chloride, 0.02 ug/mL TSP, 1 mM sodium azide, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 0.5 mM EDTA	90% H2O/10% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 800
5	3D HNCO	10 mM TRIS, 150 mM sodium chloride, 0.02 ug/mL TSP, 1 mM sodium azide, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 0.5 mM EDTA	90% H2O/10% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 800
6	3D HNCACO	10 mM TRIS, 150 mM sodium chloride, 0.02 ug/mL TSP, 1 mM sodium azide, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 0.5 mM EDTA	90% H2O/10% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 800
7	2D 1H-15N HSQC	10 mM TRIS, 150 mM sodium chloride, 0.02 ug/mL TSP, 1 mM sodium azide, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 0.5 mM EDTA	90% H2O/10% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 800
8	2D 1H-13C HSQC aliphatic	10 mM [U-2H] TRIS, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 150 mM sodium chloride, 1 mM sodium azide, 0.02 ug/mL TSP, 0.5 mM EDTA	100% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 950
9	2D 1H-13C trosy aromatic	10 mM [U-2H] TRIS, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 150 mM sodium chloride, 1 mM sodium azide, 0.02 ug/mL TSP, 0.5 mM EDTA	100% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 800
10	3D 1H-15N NOESY	10 mM TRIS, 150 mM sodium chloride, 0.02 ug/mL TSP, 1 mM sodium azide, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 0.5 mM EDTA	90% H2O/10% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 950
11	3D 1H-13C NOESY aliphatic	10 mM TRIS, 150 mM sodium chloride, 0.02 ug/mL TSP, 1 mM sodium azide, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 0.5 mM EDTA	90% H2O/10% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 950
12	3D HCCH-TOCSY	10 mM [U-2H] TRIS, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 150 mM sodium chloride, 1 mM sodium azide, 0.02 ug/mL TSP, 0.5 mM EDTA	100% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 800
13	3D 1H-15N TOCSY	10 mM TRIS, 150 mM sodium chloride, 0.02 ug/mL TSP, 1 mM sodium azide, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 0.5 mM EDTA	90% H2O/10% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 800
14	3D 1H-13C TOCSY	10 mM [U-2H] TRIS, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 150 mM sodium chloride, 1 mM sodium azide, 0.02 ug/mL TSP, 0.5 mM EDTA	100% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 800
15	3D 1H-13C NOESY aromatic	10 mM [U-2H] TRIS, 0.35 mM [U-13C; U-15N] 15th Fibronectin III domain from human fibronectin, 150 mM sodium chloride, 1 mM sodium azide, 0.02 ug/mL TSP, 0.5 mM EDTA	100% D2O	161 mM	6.5	1 bar	298	Bruker AvanceIII 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AvanceIII	800
3	Bruker	AvanceIII	950

NMR Refinement
Method	Details	Software
simulated annealing		ARIA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CcpNmr Analysis	2.4.0	CCPN
2	structure calculation	ARIA	2.3	Linge, O'Donoghue and Nilges
3	processing	TopSpin		Bruker Biospin
4	peak picking	CcpNmr Analysis	2.4.0	CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.